Literature DB >> 15777846

Hsp90 inhibitor geldanamycin increases hsp70 mRNA stabilisation but fails to activate HSF1 in cells exposed to hydrostatic pressure.

Mika A Elo1, Kai Kaarniranta, Heikki J Helminen, Mikko J Lammi.   

Abstract

High hydrostatic pressure (HP) increases Hsp70 protein and mRNA levels by increasing the mRNA half-life without activation of HSF1 transcription factor. We investigated whether this change in gene expression requires Hsp90, previously shown to regulate hsp70 genes via HSF1. In HeLa cells, both HP and Hsp90 inhibitor geldanamycin (GA) up-regulated Hsp70 expression through mRNA stabilisation. GA, unlike HP, increased HSF1 activation. However, when exposures were used together a marked Hsp70 response was observed with mRNA stabilisation without coincidence of HSF1 activation. Our data suggests that Hsp90 is involved in hsp70 mRNA stabilisation and the HSF1 activation can be suppressed by high HP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15777846     DOI: 10.1016/j.bbamcr.2004.09.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development.

Authors:  A-L Joly; A Deepti; A Seignez; A Goloudina; S Hebrard; E Schmitt; S Richaud; E Fourmaux; A Hammann; A Collura; M Svrcek; G Jego; E Robinet; E Solary; O Demidov; E Kohli; C Garrido
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

2.  Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphoma.

Authors:  L Jin; Y Tabe; S Kimura; Y Zhou; J Kuroda; H Asou; T Inaba; M Konopleva; M Andreeff; T Miida
Journal:  Br J Cancer       Date:  2010-12-07       Impact factor: 7.640

Review 3.  Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance.

Authors:  Dea Shahinas; Asongna Folefoc; Dylan R Pillai
Journal:  Pathogens       Date:  2013-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.